Close Menu

NEW YORK – The GenomeWeb Index rose more than 9 percent in May as investors continued to reward companies' efforts to develop new diagnostics for the SARS-CoV-2 virus, as well as positive earnings reports.

The index also outperformed the Dow Jones Industrial Average, the Nasdaq, and the Nasdaq Biotechnology Index, which rose 4 percent, 7 percent, and 8 percent, respectively. Individual stock performances in the GenomeWeb Index were largely positive in May, as 24 of the 32 stocks saw gains and just eight saw losses.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.

Researchers in France are developing a new, fast test for SARS-CoV-2 that initial testing indicates may be highly accurate, the Guardian says.

In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.